"What does it mean if someone has to mortgage their house to self-fund a cancer treatment that is not reimbursed? Is that timely access at a cost the community can afford? Or, just timely access to a medicine a particular person can afford?" asked MSD's Nicola Richards.
MSD's Nicola Richards: We need to clearly define and measure timely access
October 18, 2021 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
US pricing push gets real with Australia included in comparison list
December 22, 2025 - - Latest News -
Parsimony has unfortunately become an enduring test of the institution's legitimacy
December 20, 2025 - - Latest News -
PBAC delivers a broad range of outcomes in November, including for obesity
December 20, 2025 - - Latest News -
Takeda’s next-generation psoriasis therapy delivers landmark Phase 3 results
December 19, 2025 - - Latest News -
A 'fit for purpose' HTA system will be accompanied by a 'fit for purpose' cost recovery framework
December 19, 2025 - - Latest News -
Cleo Diagnostics raises funds to accelerate US launch and advance ovarian cancer screening
December 18, 2025 - - Australian Biotech -
Actinogen crosses key milestone as pivotal Alzheimer’s trial fully enrols
December 18, 2025 - - Australian Biotech

